Expert panel develops new definition of long COVID
Jun 11, 2024
A new proposed definition for Long COVID could help patients get the help they need, a new report from the National Academies of Sciences, Engineering and Medicine says.
Nirmatrelvir-ritonavir no aid for long COVID symptoms
Jun 10, 2024
The findings based on symptoms at 10 weeks following 15-day course in vaccinated cohort.
Long COVID definitions, care models are evolving
May 20, 2024
Care models are informed by five key principles, including multidisciplinary expertise and a patient-centered approach.
Two-thirds of survivors of the most severe COVID-19 face impairment at one year
Apr 26, 2024
Physical, psychiatric and cognitive problems were seen in those discharged to long-term acute care hospitals.
One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
Nirmatrelvir-ritonavir does not speed up alleviation of COVID-19 symptoms
Apr 05, 2024
The time to sustained alleviation of COVID-19 symptoms was not significantly shorter with nirmatrelvir-ritonavir versus placebo.
A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Higher use of healthcare portal seen during COVID-19 pandemic
Mar 06, 2024
Lower portal activity was linked to older age, female sex and for Hispanic/Latinx, non-Hispanic Black and other race patients.
CDC shortens recommended COVID isolation period
Mar 01, 2024
New guidance issued Friday by the US Centers for Disease Control and Prevention recommends that Americans who test positive for COVID-19 no longer need to routinely stay home for five days.